DBV Technologies (NASDAQ:DBVT) upgraded to “buy” from Kepler Capital Markets


DBV Technologies (NASDAQ: DBVT – Get a rating) was upgraded by Kepler Capital Markets research analysts from a “hold” rating to a “buy” rating in a research note released Thursday to investors, Fly reports. The brokerage currently has a price target of €6.00 ​​($6.19) on the stock.

Other equity research analysts have also published research reports on the company. StockNews.com began coverage of DBV Technologies in a research report on Monday. They have set a “holding” rating on the stock. JMP Securities reissued a “buy” rating and issued a target price of $5.00 on DBV Technologies shares in a Wednesday, June 8 report. HC Wainwright reissued a “buy” rating and issued a target price of $10.00 on DBV Technologies shares in a Tuesday, May 3 report. Finally, Goldman Sachs Group downgraded DBV Technologies from a “buy” rating to a “neutral” rating and lowered its target price for the company from $6.00 to $1.50 in a Monday, May 9 report. Four research analysts gave the stock a hold rating and three gave the company a buy rating. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $5.63.

DBV Technologies share performance

The NASDAQ DBVT traded down $0.05 during Thursday trading hours, hitting $2.55. The stock had trading volume of 3,545 shares, compared to an average volume of 102,930. DBV Technologies has a 52-week low of $1.15 and a 52-week high of $5.99. The stock has a 50-day moving average of $2.25 and a 200-day moving average of $1.72. The stock has a market capitalization of $311.79 million, a P/E ratio of -3.75 and a beta of 1.47.

A d Invest daily

Incredible dividend map where stocks earn us an average of 26% per year!

These high-yielding stocks can net you a fortune with their massive returns and big dividends. We hold 37 and are sitting on an average total return of 659%. Since 2000, they have beaten the S&P 500 by 1,428 points and have consistently generated earnings that have CRUSHED inflation! Get in on the action here

DBV Technologies (NASDAQ: DBVT – Get a rating) last announced its results on Monday, May 2. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analyst consensus estimates of ($0.47) by $0.32. DBV Technologies posted a negative return on equity of 57.09% and a negative net margin of 929.78%. The company posted revenue of $2.55 million for the quarter, versus analyst estimates of $2.20 million. On average, equity research analysts expect DBV Technologies to post -0.69 EPS for the current year.

Institutional entries and exits

Institutional investors have recently changed their stake in the company. Advisory Services Network LLC bought a new position in DBV Technologies in Q2 for a value of approximately $26,000. Envestnet Asset Management Inc. purchased a new stake in DBV Technologies stock during Q4 for $43,000. Finally, BlackRock Inc. increased its position in DBV Technologies shares by 16.5% during the 1st quarter. BlackRock Inc. now owns 687,341 shares of the company valued at $1,093,000 after acquiring an additional 97,412 shares in the last quarter. Institutional investors hold 19.33% of the company’s shares.

DBV Technologies Company Profile

(Get a rating)

DBV Technologies SA, a clinical-stage biopharmaceutical company, is engaged in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed the Phase III clinical trial for the treatment of peanut allergy in children, adolescents and adults 4-11 years old.

See also

The Fly logo

Analyst Recommendations for DBV Technologies (NASDAQ: DBVT)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in DBV Technologies right now?

Before you consider DBV Technologies, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and DBV Technologies was not on the list.

Although DBV Technologies currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here


Comments are closed.